Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IMVT
IMVT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMVT News
Immunovant Q3 Earnings Beat Expectations with Strong Cash Position
Feb 06 2026
seekingalpha
Purcell & Lefkowitz Investigates Immunovant's Board Actions for Shareholder Breach
Jan 05 2026
PRnewswire
IMVT Options Trading Kicks Off in February 2026
Dec 19 2025
NASDAQ.COM
Should You Consider Buying Immunovant Stock Following Roivant Sciences' $350 Million Stake Increase?
Dec 18 2025
NASDAQ.COM
Immunovant (IMVT) Rises 14.0% Following $550 Million Equity Raise Backed by Roivant for IMVT-1402 - Is the Bullish Outlook Still Valid?
Dec 15 2025
Yahoo Finance
Roivant Indicates Significant Progress in Pipeline with Faster Timelines
Dec 11 2025
Benzinga
Immunovant Raises $550 Million to Support IMVT-1402 Launch for Graves' Disease
Dec 11 2025
Globenewswire
Immunovant Prices $550 Million Stock Offering to Support Graves' Disease Drug Launch
Dec 11 2025
Newsfilter
Immunovant's Stock Offering of $550M Leads to 7% Decline in Shares
Dec 11 2025
SeekingAlpha
Major Stocks Including Monday.Com, Metsera, and Profrac Holding Decline in Pre-Market Trading on Monday
Nov 10 2025
Benzinga
Cardinal Health Reports Positive Q1 Results, Alongside Guardant Health, Glaukos, C.H. Robinson, and Other Major Stocks Rising on Thursday
Oct 30 2025
Benzinga
Immunovant Rises on Acquisition Rumors
Oct 30 2025
SeekingAlpha
Explore the Details: SCHB Shows Potential for 10% Growth
Oct 10 2025
NASDAQ.COM
Noteworthy IMVT Put Options Expiring on November 21st
Sep 22 2025
NASDAQ.COM
Investigation Launched by Ex-Louisiana Attorney General: Kahn Swick & Foti, LLC Probes Immunovant, Inc. Officers and Directors - IMVT
Sep 17 2025
Globenewswire
Significant Options Trading on Thursday: IMVT, RBLX, MEG
Sep 11 2025
NASDAQ.COM
Show More News
